Relmada Therapeutics (RLMD) Return on Capital Employed Growth (5y) (2019 - 2026)
Relmada Therapeutics (RLMD) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,478.00 |
| Dec 31, 2025 | -6,743.00 |
| Sep 30, 2025 | -41,363.00 |
| Jun 30, 2025 | -33,224.00 |
| Mar 31, 2025 | -21,979.00 |
| Dec 31, 2024 | -16,103.00 |
| Jun 30, 2024 | 27,153.00 |
| Mar 31, 2024 | 123,104.00 |
| Dec 31, 2023 | 164,329.00 |
| Sep 30, 2023 | -26,194.00 |
| Mar 31, 2023 | 442,275.00 |
| Dec 31, 2022 | 32,584.00 |
| Sep 30, 2022 | 78,493.00 |
| Jun 30, 2022 | 25,981.00 |
| Mar 31, 2022 | 14,743.00 |
| Dec 31, 2021 | 7,056.00 |
| Sep 30, 2021 | 5,586.00 |
| Jun 30, 2021 | 9,929.00 |
| Mar 31, 2021 | 6,826.00 |
| Dec 31, 2020 | 8,484.00 |